ALUR.WS VS CALA Stock Comparison

PerformanceVolatilityForecastSentimentTechnicalsEarningsProfitDividend
PerformanceVolatilityForecastSentimentTechnicalsEarningsProfitDividend

Performance

ALUR.WS
10/100

ALUR.WS returned -30.00% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.

CALA
10/100

CALA returned -96.80% in the last 12 months. Based on the other stocks in it's sector with an average return of -9.81%, it's performance is below average giving it a grade of 10 of 100.

Volatility

ALUR.WS
70/100

ALUR.WS has had a higher than average amount of volatility over the last 12 months giving it a score of 70 of 100.

CALA
52/100

CALA has had a higher than average amount of volatility over the last 12 months giving it a grade of 52 of 100.

Forecast

ALUR.WS

"Forecast" not found for ALUR.WS

CALA
81/100

4 analysts offer 12-month price forecasts for CALA. Together, they have an average target of 2, the most optimistic forecast put CALA at 2 within 12-months and the most pessimistic has CALA at 2.

Sentiment

ALUR.WS

"Sentiment" not found for ALUR.WS

CALA
10/100

CALA does not have any recent conclusive social sentiment.

Technicals

ALUR.WS

"Technicals" not found for ALUR.WS

CALA
11/100

CALA receieves a 10 of 100 based on 14 indicators. 1 are bullish, 12 are bearish.

Earnings

ALUR.WS

"Earnings" not found for ALUR.WS

CALA
10/100

CALA has missed earnings 9 times in the last 20 quarters.

Profit

ALUR.WS

"Profit" not found for ALUR.WS

CALA
10/100

Out of the last 20 quarters, CALA has had 2 profitable quarters and has increased their profits year over year on 1 of them.

Dividend

ALUR.WS

"Dividend" not found for ALUR.WS

CALA
10/100

CALA has not paid a dividend in the last 5 years.

All score calculations are broken down here to help you make more informed investing decisions

Allurion Technologies, Inc. Warrants, each whole warrant exercisable to purchase 1.420455 shares of common stock at an exercise price of $8.10 per share of common stock Summary

New York Stock Exchange / ALUR.WS

Calithera Biosciences, Inc Summary

Nasdaq / CALA